Blog

Blog

  • London Drugs Customers Support CPFF
    September 1, 2017 by
    Attention – CPFF community in BC, Alberta, Saskatchewan and Manitoba — London Drugs  will be collecting donations for CPFF at the till from shoppers throughout the month of September to mark Pulmonary Fibrosis Month. Please encourage your family and friends to make a donation. Every bit helps!! Thank...
    Read more
  • Profile of Patient Support Activities in Canada: Calgary, AB
    July 28, 2017 by
    In this feature, the CPFF recognizes the incredible efforts of volunteers across Canada, and share regional experiences and successes to inspire and promote the wonderful work being done. This July we are recognizing volunteers in Calgary, AB for their hard work, dedication, and commitment to help Canadians...
    Read more
  • University of Alberta recognized by CFHI for innovative ILD program
    June 26, 2017 by
    Congratulations to the fine folks at the University of Alberta for the recognition they received for their Patient-Centred ILD Collaborative for Early Integrated Palliative Care program by the Canadian Foundation for Healthcare Improvement (CFHI). This program, along with 24 others, was selected based on its role as...
    Read more
  • CPFF Reps in BC Fight for Better Care for IPF Patients
    March 29, 2017 by
    We are very proud of our CPFF BC Board Member, George Kaminsky along with other CPFF representatives in Vancouver who launched the Report Card on the BC government today with a grade of C-. The BC Report Card is based on the CPFF IPF Patient Charter, which...
    Read more
  • CPFF Needs Assessment Survey — Thank you!!
    March 25, 2017 by
    A huge thank you to all of our CPFF community who participated in our needs assessment survey. We had a tremendous response with close to 600 individuals affected by PF who completed the survey. The valuable information and insights provided will be of great help to guide...
    Read more
  • Good treatment news for people with IPF in Quebec
    March 22, 2017 by
    OFEV™ listed as Médicament d’Exception effective March 22nd, 2017 For treatment of idiopathic pulmonary fibrosis, in persons: • whose forced vital capacity (FVC) is 50% or more of the predicted value; and • whose carbon monoxide diffusing capacity is 30% to 79% of the predicted value corrected...
    Read more
  • Attention Haligonians!!
    March 17, 2017 by
    CPFF has registered for the Halifax Bluenose Marathon Charity Challenge, May 19 – 21, 2017. If you or someone you know is affected by Pulmonary Fibrosis, please plan to participate. You can put a team together or join us on your own. The CPFF information will be...
    Read more